109 related articles for article (PubMed ID: 3850389)
1. Care and cost-justification of final filtration.
Harrigan CA
NITA; 1985; 8(5):426-30. PubMed ID: 3850389
[No Abstract] [Full Text] [Related]
2. Adding infusion therapy. How to plan and train for i.v.s.
Cousino D
Contemp Longterm Care; 1992 Jul; 15(7):56, 58, 73. PubMed ID: 10119925
[No Abstract] [Full Text] [Related]
3. An FDA update on GMP's for aseptic processing.
Fry EM
J Parenter Sci Technol; 1985; 39(4):154-7. PubMed ID: 3928863
[No Abstract] [Full Text] [Related]
4. Is filtration cost-effective in routine I.V. therapy?
Gill S
NITA; 1984; 7(3):227-9. PubMed ID: 6427709
[No Abstract] [Full Text] [Related]
5. Inadequate medical order writing and delivery: a cause of unnecessary hospital costs.
Larson EB; Dowell S; Scott DH
QRB Qual Rev Bull; 1984 Nov; 10(11):353-5. PubMed ID: 6441138
[No Abstract] [Full Text] [Related]
6. Final filtration systems in parenteral production.
Sokol M
Bull Parenter Drug Assoc; 1969; 23(2):63-8. PubMed ID: 5776420
[No Abstract] [Full Text] [Related]
7. Presidential address.
Vizcarra C
J Infus Nurs; 2008; 31(4):224-5. PubMed ID: 18641484
[No Abstract] [Full Text] [Related]
8. Evaluation of the literature on stability and compatibility of parenteral admixtures.
Trissel LA
NITA; 1985; 8(5):365-9. PubMed ID: 3900815
[No Abstract] [Full Text] [Related]
9. Techniques of intravenous infusion.
Wildsmith JA
Scott Med J; 1978 Oct; 23(4):298-306. PubMed ID: 725582
[No Abstract] [Full Text] [Related]
10. Making the NITA standards work for you.
Chrystal C
NITA; 1985; 8(5):363-4. PubMed ID: 3850382
[No Abstract] [Full Text] [Related]
11. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
[No Abstract] [Full Text] [Related]
12. Implementing intravenous policy.
Reed M
Nurs Mirror; 1985 Jul; 161(4):32-3. PubMed ID: 3848974
[No Abstract] [Full Text] [Related]
13. Quality assurance in I.V. admixture programs.
Turco SJ
Hosp Pharm; 1979 Jun; 14(6):307, 311-3. PubMed ID: 10242204
[No Abstract] [Full Text] [Related]
14. Quality care organizations collaborate on performance measurement activities.
Nephrol News Issues; 1998 Oct; 12(10):64. PubMed ID: 10196959
[No Abstract] [Full Text] [Related]
15. [Catheter embolism].
Pape KS
Ned Tijdschr Geneeskd; 1972 May; 116(21):895-6. PubMed ID: 5026097
[No Abstract] [Full Text] [Related]
16. Hazards associated with parenteral therapy.
Turco SJ
Bull Parenter Drug Assoc; 1974; 28(4):197-204. PubMed ID: 4852222
[No Abstract] [Full Text] [Related]
17. A first-phase quality assurance program for intravenous admixture aseptic technique.
Gurwich EL; Hanold L; Schaeffer P
Hosp Pharm; 1982 Mar; 17(3):119-21. PubMed ID: 10255637
[TBL] [Abstract][Full Text] [Related]
18. Standards and credentialing. A forum on quality i.v. practice.
Chrystal C; Crudi C
NITA; 1985; 8(6):463-70. PubMed ID: 3852090
[No Abstract] [Full Text] [Related]
19. Making the NITA standards work for you.
Chrystal C
NITA; 1986; 9(5):400-1. PubMed ID: 3638521
[No Abstract] [Full Text] [Related]
20. Compliance issues in 1985.
Michels DL
J Parenter Sci Technol; 1985; 39(4):158-60. PubMed ID: 4032157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
